22 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Scholarships for the 8th Biennial Conference - Cancer, Culture & Literacy: Advancing Communications
CCL Conference Dates Conference Date: May 17 – 19, 2012 Pre-conference workshops: May 17, 2012 Main Conference: May 17 – 19, 2012
The Cancer, Culture and Literacy Conference offers extraordinary networking and learning opportunities for individuals wanting to learn more about the roles of culture, language and literacy in cancer health disparities and in the design, implementation and evaluation of cancer communications, programs and educational interventions. Hosted by Moffitt Cancer Center, the conference provides a national forum for the exchange and dissemination of information covering current research, innovative communications, novel training programs, and emerging education practices.
This three-day conference offers a number of interactive activities including pre-conference skill-building workshops, plenary and breakout sessions, breakfast roundtables and a poster session. The conference curriculum features community-based participatory research (CBPR) approaches and qualitative methods to inform the development of cancer education media/materials and intervention design.
Conference participants include healthcare professionals, community health workers, advocates and survivors involved in developing cancer communications, innovative materials/media, educational programs and interventions that are tailored to cultural, linguistic and literacy needs of community members, Patients and cancer survivors. A variety of professional accreditation and continuing education contact hours will be offered.
The conference facilitates our understanding of cancer awareness and educational needs in diverse social, cultural, and literacy contexts. Ultimately, the goal is for attendees to incorporate culture and literacy components into the development of their communications, research, educational and outreach programs.
In an effort to assist conference registrants who have limited funding to attend conferences, we are able to offer some scholarships. The application process is online and opens on January 18, 2012.
Opens: January 18, 2012, 8:00am EST. Closes: March 5, 2012, 5:00pm EST.
Notifications will be made: March 16, 2012
Conference Contacts
Mailing address:
Moffitt Cancer Center Attn: Cindy Burcham 12902 Magnolia Drive, FOW-EDU Tampa, FL 33612
Email address: CCL2012@moffitt.org
Phone number: 813-745-6031
Course Director: Cathy D. Meade, PhD, RN, FAAN
Conference Planner: Chrystyna Pospolyta, MPH
Cure4Kids for Kids Global eHealth Challenge
Sponsored by St. Jude Children’s Research Hospital, Cure4Kids for Kids is seeking university, high school, middle school, and elementary school students to develop innovative multimedia experiences that educate children about cancer and healthy living for cancer prevention.
Submit a website, video, podcast, app for mobile device, game, or other multimedia project with a focus on the following topics, Cancer & Tobacco or Cancer & Ultraviolet Rays*.
Grand Prize is an Apple iPad and Internship at St. Jude Children’s Research Hospital** All entries must be submitted online at www.cure4kids.org/challenge Teams or individuals may enter
Accepting submissions from January 1, 2012 through April 2, 2012
* No purchase necessary. Students 17 years and younger must have mentor or adult sponsor. ** Only students 16 years and older are eligible for internship.
Call for Applications: 2012 Raymond and Maria Floyd Award for Bladder Cancer Research
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that we are now accepting applications for the 2012 Raymond and Maria Floyd Award for Bladder Cancer Research. This award is made possible by World Golf Hall of Famer Raymond Floyd and his wife, Maria, who have made a six-figure gift to the organization in support of advancing necessary research efforts to help those who have been profoundly affected by bladder cancer, the nation’s 5th most common form of cancer.
This $25,000 grant will cover direct costs associated with a one year bladder cancer-specific research proposal. The purpose of this grant is to advance research that will increase the understanding of bladder cancer risk, biology, prevention, and treatment while encouraging young investigators to pursue a career in bladder cancer research.
BCAN is eager to review all qualified applications, and we encourage you to distribute this grant information to any young researchers interested in investigating bladder cancer.
At the time the application is submitted, applicant must be a resident, graduate student, clinical research fellow, post-doctoral fellow, or junior faculty at an academic facility, teaching hospital or research institution at the time of application. Faculty members are eligible if within the first 5 years of faculty appointment.
The project must be bladder cancer-specific.
Completed applications must be submitted electronically to grants@bcan.org by March 29, 2012. The grant recipient will then be determined by a selection committee comprised of physicians and research specialists in bladder cancer. The award will be announced on or before May 19, 2012, and the grant period will begin on July 15, 2012. The grant recipient will be expected to present results at BCAN’s annual Bladder Cancer Think Tank Meeting in August, 2013.
Please contact BCAN if you have any questions. You can reach us at grants@bcan.org.
Fellowship in Cancer Communication Research
The Penn Center of Excellence in Cancer Communication Research (CECCR) at the University of Pennsylvania’s Annenberg School for Communication is offering a research fellowship in cancer communication for the Fall 2012 term. This two-year fellowship program offers training in communication research and theory relevant to cancer prevention and control. The advanced, rigorous training and experience provided will prepare the fellows for careers as independent investigators in cancer communication research.
The mission of the NCI-funded CECCR at Penn is to examine how messages from a range of sources in the complex communication environment affect cancer-related behavioral choices, including lifestyle, screening and care-seeking choices. Previous research has included experimental and observational field studies focused on information seeking and scanning concerning cancer, understanding the interaction of public communication and clinical services as they affect cancer-related decisions and outcomes, the effects of news media about genetic information and the effects of anti-smoking and smoking advertising campaigns.
The Penn CECCR Fellows will obtain skills and experience to complement previous advanced work in communication, public health, behavioral science or biomedical research. Fellows with training in communication research can focus on cancer-related training; those with background in cancer research will focus on communication theory and research. Fellows will work closely with mentors in such areas as cancer epidemiology, health policy, behavioral theory, persuasion theory, risk and decision-making, psychophysiology as well as health communication. Fellows will participate in research in cancer communication using survey, experimental, and content analytic methods and will receive guidance in the preparation of manuscripts and career development grants.
Applicants must have training in social science or behavioral research methods and have received a PhD or an equivalent degree from an accredited institution. Applicants with an MD and at least one year of clinical research training will also be considered. To obtain additional information or apply, please contact Joseph Cappella, Ph.D. (215-746-3400, ceccrfellow@asc.upenn.edu), Gerald R. Miller Professor of Communication, Annenberg School for Communication, University of Pennsylvania, 3620 Walnut Street, Philadelphia, PA 19104. If applying, include letter of introduction, CV, and names of 3 references. Applications will be considered on a continuing basis. To be assured of full consideration for a 9/1/2012 start date please respond by February 15, 2012.
Request for Applications: Prostate Cancer Foundation-Honorable A. David Mazzone Special Challenge Award Research Program 2012
The Prostate Cancer Foundation (PCF) is pleased to announce the PCF-Honorable A. David Mazzone Special Challenge Award Research Program 2012.
These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe.
These awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high impact clinical investigation.
IMPORTANT:
The online application submission form will go live at www.pcfscience.org after February 15, 2012.
The deadline for application submission is March 16, 2012.
Dr. Howard R. Soule Executive Vice President Chief Science Officer Prostate Cancer Foundation 1250 4th Street Santa Monica, CA 90401
Call for Applications: Summer Undergraduate Research Fellowship Program at the Ernest Mario School of Pharmacy - Rutgers University
The Ernest Mario School of Pharmacy announces the 2012 Summer Undergraduate Research Fellowship (SURF) Program. The program is intended for highly motivated undergraduates interested in a career as a researcher in the pharmaceutical and environmental sciences. Students are provided with an opportunity to conduct full-time research in areas related to Pharmacology and Toxicology, Environmental Health Sciences, Pharmaceutics, Medicinal Chemistry, Chemical Biology, and Clinical Pharmacy Research. The program is open to undergraduate students enrolled at Rutgers or at another university. Student should be sophomores, juniors, or seniors at the time of application. Previous experience performing independent laboratory or clinical research is not required.
This 10-week program will run May 21 through July 27, 2012 and provides a $2,800 stipend. Funding for room and board is not available. Students must be available for the entire 10-week period. Training includes hands-on research conducted in the laboratories or clinical practices of faculty members, round table discussions of research progress, and seminars on research careers and activities of the faculty. Students also participate in career development workshops. At the end of the fellowship, each student will provide a brief oral presentation on his or her summer research project.
To apply to the Summer Research Fellowship Program, the following items are required:
· Completed application form
· College transcripts (current and previously attended universities)
· Personal statement
· Two letters of recommendation
Applications must be typed and submitted in a single envelope. Letters of recommendation should be in sealed envelopes and included in the envelope with the completed application form, transcripts, and personal statement. All application materials must be received/postmarked by February 15, 2012. Only complete applications will be reviewed.
For further information, please contact Dr. Debra Laskin by email at laskin@eohsi.rutgers.edu or Dr. Lauren Aleksunes at aleksunes@eohsi.rutgers.edu. Students selected for the program will begin to be notified March 26, 2012. Students will have 1 week to notify the Program of their intent to participate. Notifications of selected students will be made through April 9, 2012. Students who are not selected will be notified by April 16, 2012.
Note: Pharmacy students selected for the SURF program will be placed into Cycle III for their pharmacy practice experience.
Send completed applications to:
Ms. Cindy Olexsa Dean’s Office Ernest Mario School of Pharmacy Rutgers University 160 Frelinghuysen Road Piscataway, NJ 08854
The SURF Program at the Ernest Mario School of Pharmacy is financially supported by the National Institute of Environmental Health Sciences (1R25ES020721), the American Society for Pharmacology and Experimental Therapeutics, the UMDNJ Graduate School of Biomedical Sciences, and the Dean of the School of Pharmacy.
General Research Areas
Pharmacology, Toxicology and Environmental Health Sciences: neurotoxicology; immunology; inflammatory mechanisms of tissue injury; kidney injury; role of extracellular matrix in development and disease pathology; wound healing; nitric oxide biology; pulmonary toxicology, developmental toxicology; environmental health sciences
Medicinal Chemistry: design and synthesis of enzyme inhibitors and prodrugs; synthetic organic chemistry, structure activity relationships, medicinal chemistry
Pharmaceutics: design, development and evaluation of drug delivery systems; biopharmaceutics (drug formulation, drug transport); pharmacokinetics
Chemical Biology: cancer biology and prevention; regulation of tumor cell growth and differentiation
Pharmacy Practice: clinical studies; diabetes, hypertension, and medication therapy management
Call for Applications: M.D./Ph.D. Summer Undergraduate Research Program at the University of Nebraska Medical Center
Goals of the Summer Research Program
The University of Nebraska Medical Center strongly believes that the training of physician-scientists is critical to the future of medicine. Physician-scientists play a unique role in biomedicine by studying patients and their diseases.
To accomplish this, we wish to recruit highly qualified students into medical and research programs at the University of Nebraska Medical Center. The summer research program described here will provide appropriate experience and training to enable students to become competitive for admission into our M.D./Ph.D. Scholars Program.
This summer research program is for individuals that are motivated for success in careers combining medicine and research. Although we are especially interested in undergraduate students who are currently in their sophomore year of college, current freshman and juniors are also encouraged to apply. Some research background may be useful in order to maximize your laboratory experience.
This is a great opportunity for students to discover first-hand the broad spectrum of research activities being performed at the University of Nebraska Medical Center. Not only will students be doing research, but successful applicants will also have the opportunity to shadow physicians. This gives students a chance to not only experience great science but to also experience the doctor/patient relationship side of medicine. We can provide a summer of challenges and exceptional learning experiences.
A wide variety of exciting research projects are available, from studies at the molecular level to patient oriented clinical research and healthcare outcomes research. Cancer Biology, Cardiovascular Biology, Cell and Developmental Biology Cell Signaling, Genetics, Immunology, Molecular Biology, and Neuroscience are some of the programs available to students for their summer research projects.
Why Should You Participate?
Benefits include:
Gaining research training and experience that will make you more competitive for medical school, graduate school, other summer research programs, and M.D./Ph.D. Programs Becoming familiar with UNMC and its faculty, students and programs The UNMC faculty will get to know you and your potential Exploring your personal motivation for a career in medicine and biomedical research Discovering all of the exciting research going on at UNMC Participating in a student poster session Understanding how discoveries made in the laboratory are translated into new methods of prevention, diagnosis, and treatment of human disease Research is fun and rewarding AND, we will PAY you to do it. A stipend of $3,000 for approximately 10 weeks of participation.
The Summer Research Program, like the M.D./Ph.D. Scholars Program, is highly competitive, and candidates that are successful in securing a slot in the summer program will have outstanding academic records.
You can apply online to participate in this program. In addition to the application, the student must send the following information to the address below:
A one- to two-page essay describing their interest in medicine and research. Be sure to indicate your general (or specific) area of research interest in your essay. A current transcript (also include a high school transcript if currently a freshman). SAT or ACT scores (required for all applicants). At least one letter of reference from a faculty member at your current college or university.
The goal would be to place students in the areas that interest them the most.
Students in the program will be required to participate in a Summer Undergraduate Research Poster Session. Students, with the help of their faculty advisor, will develop a poster for the session
The deadline for receipt of applications is March 1.
Additional information may be obtained by calling (402) 559-8242 or (877) 269-0029. Feel free to e-mail Sonja Cox with any questions at sacox@unmc.edu
Application materials should be sent to:
Sonja Cox University of Nebraska Medical Center 985520 Nebraska Medical Center Omaha, NE 68198-5520 fax: (402) 559-8266
Damon Runyon Clinical Investigator Award
Application deadline date for this award: February 15, 2012
The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
The Clinical Investigator Award responds to three recognized realities:
Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low. The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.
The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.
Building on the long-term success of the Damon Runyon Postdoctoral Fellowships, the creation of the Clinical Investigator Award is a logical extension of the Foundation’s overall mission to defeat cancer. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators.
Definition of Clinical Research
For the purposes of this award, the Foundation’s definition of clinical research will follow the definition set out in “The NIH Director’s Panel on Clinical Research Report to The Advisory Committee to The NIH Director,” December, 1997.
a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers. b) Epidemiologic and behavioral studies. c) Outcomes research and health services research.
Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.
Preference will be given to research that adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients.
Partnership with NIH and NCI
Damon Runyon has a novel partnership with the National Institutes of Health (NIH) and the National Cancer Institute (NCI), which uniquely opens access to the NIH Clinical Center (CC) to Damon Runyon Clinical Investigators. The goal of this partnership is to use the special talent, expertise and resources of the participants to undertake pilot studies of specific diseases and to develop collaborative partnerships that accelerate clinical and translational cancer research, and thereby improve human health.
Potential opportunities for pilot partnership:
1. Damon Runyon Clinical Investigator Award applicants may apply with a mentor or co-mentor from NCI or another NIH Institute. The proposal must identify the research to be done at and resources to be used at the NIH CC.
2. Current Damon Runyon Clinical Investigators may conduct a research project at the NIH CC in collaboration with an NIH tenured/tenure-track investigator. The Damon Runyon Clinical Investigator would be the PI or co-PI on the project.
3. Current Damon Runyon Clinical Investigators may request to use the special equipment or facilities at the NIH CC, which could provide opportunities for investigators that may not be possible in their home institutions. Examples are: obtaining research materials such as research PET ligands or products from the CC Good Manufacturing Practice (GMP) facilities, or accessing other non patient-related activities/facilities. No NIH scientist collaboration would be required.
Please contact the Foundation’s Chief Scientific Officer, Yung Lie, with any questions regarding NIH/NCI partnership opportunities (212.455.0521).
Research, Training and Development
During each year of the award, the applicant must commit a minimum of 80% of their full-time professional effort to the conduct of research and research career development.
The Mentor’s role is to foster the development of the applicant’s knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels. Selection and Review
The Clinical Investigator Award Committee (CIAC) will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation's Board of Directors. CIAC puts a premium on innovation and creativity when reviewing applications.
Selection Criteria
Excellence of the applicant and mentor. Innovation, creativity, quality and originality of the research proposal. The commitment of the mentor and institution to the development and training of the applicant as a skilled clinical research investigator. Evidence of the applicant’s commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems. Importance of the proposed research to the field of cancer and/or cancer prevention. Adherence of the proposal to the definition of clinical research as set out on this web page. Adherence to the “Handshake Rule.”
Program Sponsors
Under the leadership of the Damon Runyon Cancer Research Foundation, the Clinical Investigator Award is funded in part through Accelerating Cancer Cures, a collaboration of the biopharmaceutical industry, academia and young researchers formed to achieve breakthroughs against cancer by rebuilding the ranks of brilliant and committed clinical investigators who can translate science into cures. Members include: Eli Lilly and Company, Celgene, Merck, Millennium: The Takeda Oncology Company, Pfizer and The Pharmaceutical Research and Manufacturers of America (PhRMA).
Eligibility
The applicant must be a U.S. citizen or permanent legal resident. Each applicant must be nominated by his/her institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation http://www.damonrunyon.org/for_scientists/more/invited_institutions/
Three (3) nominations per institution, including its affiliated schools, will be accepted. Because of its number of affiliated hospitals, Harvard Medical School may submit up to six (6) nominations.
The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible.
The applicant may apply within the first four (4) years of his/her initial full faculty appointment after the final year of his/her subspecialty training (Adjunct or acting positions are not eligible).
Candidates may apply up to three times during this eligibility period. Candidates holding or awarded R01s at the time of application are not eligible to apply.
The applicant must commit to spending 80% of their time conducting research.
The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.
Funding
The $450,000 award will be for a period of three years. Funding in the amount of $150,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s stipend and/or fringe benefits (up to $100,000), salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research. No part of this grant can be used for indirect costs or institutional overhead.
Other Funding
Investigators may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source (non-federal government) may be held concurrently with the Clinical Investigator Award.
Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g., K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.
Scientific or budgetary overlap with other funded projects is not allowed. Therefore, it is critical that all current and pending grant support for your research be reported to the Foundation and the relationship of that support to the Damon Runyon funded project be explained.
Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to):
AACR- Career Development Award American Cancer Society- Mentored Research Scholar Grants in Applied and Clinical Research ASCO- Career Development Award Burroughs Wellcome Fund- Career Award for Medical Scientists Doris Duke Charitable Foundation- Clinical Scientist Development Award Howard Hughes Medical Institute- Physician-Scientists Early Career Award, Early Career Scientist Competition Kimmel Foundation- Kimmel Translation Science Award, Kimmel Scholar Award Leukemia and Lymphoma Society- Career Development Program, Scholar Awards
Please contact the Foundation with any questions regarding concurrent funding (212.455.0520). Debt Repayment Program
The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee.
Contact Information: Award Programs | 212.455.0520 | awards@damonrunyon.org
Call for Applications: Dr. Josef Steiner Cancer Research Award 2013
The Dr. Josef Steiner Cancer Foundation announces that it is accepting applications for the 2013 Cancer Research Award. The award consists of financial support for a cancer-related research project in the maximal amount of CHF 1'000'000.- over four years and, in addition, a personal prize in the amount of CHF 50'000.- awarded to the successful principal investigator. The award and price will be presented to the successful candidate in October 2013 at a public ceremony at the University of Bern, Switzerland.
With this award it is the intent of the Dr. Josef Steiner Cancer Foundation to support an outstanding project by an innovative investigator early in her or his career. Projects in both basic research and clinical investigations (translational research) are eligible. The award money may be used for salaries of project co-investigators or staff, equipment and any other costs related to the project. The funds cannot be used to support the salary of the principal investigator. The applicant must provide evidence of his professional affiliation and current position as well as of the availability of the infrastructure needed to carry out the proposed project.
The award money is provided in four annual instalments. The Foundation makes the last three payments conditional upon submission of a yearly progress report. Representatives of the Foundation may visit the research group once during the four-year award period. Under no circumstances can the support be extended beyond four years. The Foundation expects written acknowledgments of its support on all reports published. Evaluation Procedure
The evaluation for the 2013 Prize will take place in three steps. Candidates must first submit a project outline on the official application forms which can be downloaded from www.steinerstiftung.unibe.ch. The completed application and requested documents must be submitted to the president of the Foundation by e-mail with a single attached PDF file. The applications will then be evaluated by the Scientific Advisory Board of the Foundation. The applicants of the best five to six submissions will be invited to submit a detailed research project. These projects will again be evaluated by the Scientific Advisory Board with the additional help of outside referees. The short-listed candidates will be invited for an interview. The final decision on the successful applicant will be made on the recommendation of the Scientific Advisory Board by the Council of the Foundation.
Deadline for submission of the project outline: March 31st 2012.
The five to six successful applicants will be notified by the Foundation not later than June 30th 2012. Deadline for submission of detailed research project: August 31st 2012.
The interviews will take place in January, 2013 in Bern, Switzerland.
The Prize Winner will be notified by the Foundation not later than January 31st 2013. The research work should start between February and December 2013.
Objectives of the Dr. Josef Steiner Cancer Research Foundation
The objectives of the Dr. Josef Steiner award are:
to honor outstanding cancer research: new basic concepts, new diagnostic or therapeutic approaches and preventive methods;
to encourage those individuals who have contributed to basic knowledge of cancer by their systematic research work;
to educate the public that cancer research progress is realized in a step by step manner;
to honor even small advances in the hope that a major breakthrough in cancer research will sooner or later occur.
Funderburg Research Award in Gastric Cancer
One award is made to support the research of an established investigator working on novel approaches to gastric cancer.
AT A GLANCE Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: 2 years Deadline: Aug. 31 Start Date: Jan. 1
DESCRIPTION This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.
OBJECTIVE The overall objective of this award is to support an established investigator in the field of gastric biology whose research will enhance the fundamental understanding of gastric cancer pathobiology in order to ultimately prevent or develop a cure for the disease.
ELIGIBILITY Candidates for this award must hold a full-time faculty position at an accredited North American institution and must be established as an independent investigator in the field of gastric biology.
Women and minority investigators are strongly encouraged to apply.
AGA membership is required at the time of application submission. Please visit www.gastro.org/membership or call 301-654-2055, extension 651, for membership information.
REQUIREMENTS A letter of recommendation should be provided by the division chief or chair of the department of medicine and should outline support of the candidate and his/her research program.
Funds are to be used for the salary support, equipment and supplies of the investigator to promote his/her research. Indirect costs are not allowed.
Upon receipt of award notification, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Annually, a one-page plain-language progress report, a scientific progress report, a financial report and a list of publications based on the research must be submitted by the award recipient on or before January 31. Second-year funding is contingent upon submission of this documentation.
All publications, presentations and abstracts arising from work funded by this program must acknowledge support from the AGA Research Foundation R. Robert & Sally D. Funderburg Research Award in Gastric Biology.
AWARD OVERLAP If a candidate is granted the award and notified of a comparable award from another agency prior to the first payment of this award, the applicant must select one of the two awards. (i.e. the recipient may not retain both awards).
SELECTION CRITERIA The recipient will be selected based on novelty, feasibility and significance of the proposal. Preference will be given to novel approaches.
REVIEW PROCESS A selection committee composed of members of the AGA Research Awards Panel will review the proposals and determine the award recipient. Funding will commence in January.
APPLICATION PROCESS The application deadline date for this award is Aug 31. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please e-mail the application document to awards@gastro.org. The applicant's full name and project title are to be included in the submission e-mail. Please direct all questions to the Research Awards Manager via telephone at 301-222-4012 or e-mail at awards@gastro.org.
Support for this award by the R. Robert and Sally D. Funderburg Charitable Trust is gratefully acknowledged.
123next
